Close Menu

The Scan

The Gizmodo blog urges readers to kick in cycles for the Folding@home proteomics project.

A Taipei-based effort will set up a genetic database to help screen for promising athletes.

Crying Wolf?

A Seoul scientist says he successfully cloned wolves.

Learning to Speak

A new bill wants to train science grad students in communication.

Treating deadly diseases is all fun and games till they start swapping genes with other organisms to resist therapy.

A consumer group released a report saying that FDA's plan to allow the sale of cloned livestock products was based on little data and too much biotech lobbying.

This Week in Science

GTO wraps up this week's edition of Science.

Getting Personal

A blogger reports on how personalized medicine has made headway in clinical trials for multiple myeloma.

Try, Try Again

A genetic nondiscrimination bill that's been floating around the US Congress for the past 12 years now looks like it may be passed.

This Week in Nature

GTO scans today's issue of Nature.

The Father of Fortran

The developer of the Fortran programming language dies at 82.

Pinching Pennies

Scientists are already feeling the effects of the NIH budget crunch.

Is trying to thwart malaria worth the unknown factors in releasing genetically modified mosquitoes into the environment? The jury's still out.

A blogger tackles the criticism leveled at the Cancer Genome Atlas project.

The Genes Went Poof

In six years, 8,000 human genes became no more.

The latest PNAS issue features a paper on recombination hotspots.

Google's Summer of Code event will include opportunities to help out the Phyloinformatics Group.

NIH Director Elias Zerhouni says the US must change its policy on stem cell funding.

An article online at Newsweek says the Cancer Genome Atlas could be a colossal waste of funding.

Just in case you were in a happy mood, here's a post on why genomic technologists should remember the cautionary tale of the eugenics movement.

As genetic testing is possible for more diseases, there's growing debate over the value of such tests when there's nothing to be done about the illness.

There's controversy brewing over how to regulate generic versions of biotech drugs.

An article in Forbes presents the argument that if we don't understand our own cellular network, we can't possibly expect to make it work better.

This Week in Science

Here are the articles worth your time in this week’s Science.

The latest version of Sony's PlayStation lets users contribute to a global proteomics project.


Researchers who go persevere after an early funding setback end up with more highly cited papers later on, according to the Economist.

Nature News reports that female scientists setting up their first labs tend to have lower salaries and smaller staffs than their male peers.

A new analysis by Northwestern University researchers finds that female and male first-time PIs receive differing amounts of funding.

Some 43 percent of new mothers and 23 percent of new fathers leave full-time employment in STEM in the years after having a child, Science Careers says.